7733 On Other Exchanges
Symbol
Exchange
7733 is not on other exchanges.

olympus corp (7733) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for OLYMPUS CORP (7733)

Related News

No related news articles were found.

olympus corp (7733) Related Businessweek News

View More BusinessWeek News

olympus corp (7733) Details

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates in four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others Business. The Medical Business segment offers endoscopy systems comprising videoscopes, video processors, light sources, and liquid crystal display panels; peripheral equipment, such as image recording devices, endoscope cleaning systems, sterilization systems, etc.; surgical video endoscopy systems, peripheral devices for endoscopic surgery, electrosurgical knives, etc.; and endoscopic devices for various diagnostic and treatment procedures, including biopsy forceps, high-frequency polypectomy snares, grasping forceps, stone retrieval and lithotriptor baskets, hemostasis accessories, etc. The Scientific Solutions Business segment provides upright and polarizing microscopes, inverted microscopes, laser confocal microscopes, box-type fluorescence imaging devices, stereo microscopes, fluorescence macro microscopes, microscope digital cameras, imaging software, bio-imaging systems, and virtual slide systems; and metallurgical microscopes, semiconductor inspection microscopes, laser and measuring microscopes, microscopic 3D measurement systems, industrial videoscopes and fiberscopes, industrial rigid scopes, ultrasonic flaw detectors, eddy current flaw detectors, phased array flaw detectors, x-ray diffraction analyzers, and peripheral equipment. The Imaging Business segment offers digital single-lens cameras, compact digital cameras and related products, digital camera lens barrels, and optical components, as well as IC recorders and binoculars. The Others Business segment provides biomedical materials, as well as conducts system development and other business activities. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

33,336 Employees
Last Reported Date: 06/28/16
Founded in 1919

olympus corp (7733) Top Compensated Officers

President and Representative Director
Total Annual Compensation: ¥106.4M
Compensation as of Fiscal Year 2016.

olympus corp (7733) Key Developments

Olympus Launches New Industrial Video Scope

Olympus Corporation has announced the launch of the IPLEX NX, an industrial videoscope, by its Scientific Solutions Business. It supports more accurate and efficient inspection with features that include the best brightness and image quality in the IPLEX series. Industrial endoscopes are a form of non-contact inspection system suitable for use in confined and hard-to-access spaces that are not open to direct visual inspection, such as the interior of aircraft engines or piping at industrial plants. Their main uses include routine maintenance and inspecting components for quality. Olympus has marketed a variety of models under its IPLEX series of industrial videoscopes that satisfy diverse requirements through high image quality and excellent usability. The new IPLEX NX is the successor to the top-end IPLEX FX model and represents the first full model change in seven years. The IPLEX NX helps improve inspection efficiency by featuring the best brightness and image quality in the IPLEX series together with a significantly enhanced stereo measurement function. It is also designed to be easier for operators to use, with a newly developed electrically operated bending mechanism that makes the videoscope easier to operate. In addition to these technologies, the new model also features the same high reliability and durability in harsh environments that are a hallmark of the series to support more precise and efficient inspection. The IPLEX NX utilizes Olympus's optics technology to provide by far the best brightness and image quality in the IPLEX series. It can capture crisp images by providing bright illumination even in hard-to-access spaces such as the interior of gas turbines where external lighting can't reach. Furthermore, by providing illumination over a wide area, it facilitates observation of the desired location. This helps improve the efficiency of inspection. Olympus has dramatically enhanced the stereo measurement function that simplifies the measurement of the size and depth of defects from various angles. The IPLEX NX is able to perform measurement over roughly four times the area of previous models. It also incorporates a way of measuring object distances at five points. This enables measurement over a wide area. Olympus has dramatically enhanced the stereo measurement function that simplifies the measurement of the size and depth of defects from various angles. The IPLEX NX is able to perform measurement over roughly four times the area of previous models. It also incorporates a way of measuring object distances at five points. This enables measurement over a wide area.

Olympus Announces the Launch of Its FDA Cleared Plasma-Oval button

Olympus, announced the launch of its FDA cleared Plasma-Oval button for urologic procedures including minimally invasive surgery to reduce enlarged prostate as well as treatment of bladder cancer. The Plasma-Oval button uses Olympus plasma technology in a revolutionary electrode shape designed to maximize O.R. efficiency and enhance clinical outcomes.

Olympus to Pay $306 Million to Settle Civil Lawsuit

Olympus will pay a total of $306 million to settle a civil lawsuit that alleged Olympus and its subsidiaries got doctors and hospital executives to buy endoscopes and surgical equipment by offering improper financial incentives. This allowed the company to unlawfully increase its sales and gain market share, the lawsuit claimed. The civil settlement, first announced in March, is in addition to about $312 million criminal penalty. The company agreed to pay a total of about $646 million, and to a corporate integrity agreement with the U.S. Department of Health and Human Services Office of the Attorney General.

 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

7733 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 7733.
View Industry Companies
 

Industry Analysis

7733

Industry Average

Valuation 7733 Industry Range
Price/Earnings 22.6x
Price/Sales 1.8x
Price/Book 3.7x
Price/Cash Flow 13.8x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OLYMPUS CORP, please visit www.olympus-global.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.